Company research
Alpha Tau Medical Ltd.
CIK 1871321Updated Sep 27, 2026
DRTS price & chart
Loading TradingView…
NASDAQ:DRTS on TradingView ↗In the news
Alpha Tau Announces First-Ever Oral Presentation of Alpha DaRT® Pancreatic Cancer Data at Digestive Disease Week (DDW) 2026 ↗
Seeking Alpha
Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More ↗
Alpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM Breakthrough ↗
Alpha Tau rises on Alpha DaRT head and neck cancer data ↗
SEC disclosures
Alpha Tau Medical Ltd. IPO declared effective by SEC ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 105,652,000Source | 86,204,000Source | 107,388,000Source | 120,149,000Source |
| Property, Plant and Equipment, NetUSD | 19,661,000Source | 13,934,000Source | 12,798,000Source | 7,471,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 12,202,000Source | 13,724,000Source | 12,657,000Source | 5,836,000Source |
| Assets, CurrentUSD | 78,298,000Source | 64,229,000Source | 85,756,000Source | 106,477,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,395,000Source | 1,374,000Source | 816,000Source | 1,097,000Source |
| Operating Lease, Right-of-Use AssetUSD | 7,214,000Source | 7,609,000Source | 8,363,000Source | 5,810,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 28,553,000Source | 23,538,000Source | 22,913,000Source | 14,492,000Source |
| Stockholders’ equity: | ||||
| Additional Paid in CapitalUSD | — | — | 200,234,000Source | 192,259,000Source |
| Retained Earnings (Accumulated Deficit)USD | -190,136,000Source | -147,509,000Source | -115,759,000Source | -86,602,000Source |
| Stockholders' Equity Attributable to ParentUSD | 77,099,000Source | 62,666,000Source | 84,475,000Source | 105,657,000Source |
| Additional Paid in Capital, Common StockUSD | 267,235,000Source | 210,175,000Source | — | — |
| Liabilities and EquityUSD | 105,652,000Source | 86,204,000Source | 107,388,000Source | 120,149,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 10,507,000Source | 8,675,000Source | 7,102,000Source | 4,338,000Source |
| Operating Lease, Liability, CurrentUSD | 1,131,000Source | 1,011,000Source | 1,062,000Source | 669,000Source |
| Accounts Payable, CurrentUSD | — | — | 2,566,000Source | 1,423,000Source |
| Operating Lease, Liability, NoncurrentUSD | 6,243,000Source | 5,964,000Source | 6,604,000Source | 4,524,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 3,784,000Source | 2,615,000Source | 2,236,000Source | 1,276,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 76,903,000Source | 62,855,000Source | 84,940,000Source | — |
| Deferred Tax Liabilities, NetUSD | 1,025,000Source | — | — | — |
| Short-term InvestmentsUSD | 60,924,000Source | 45,876,000Source | 69,131,000Source | 98,694,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 10,617,000Source | 9,916,000Source | 7,926,000Source | 6,748,000Source |
| Deferred Income Tax Expense (Benefit)USD | 97,000Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -26,681,000Source | -19,783,000Source | -17,958,000Source | -23,879,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -20,588,000Source | 20,768,000Source | 18,682,000Source | -89,936,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 6,075,000Source | 2,238,000Source | 6,401,000Source | 904,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 45,768,000Source | 25,000Source | 5,297,000Source | 96,905,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -1,522,000Source | 1,067,000Source | 5,971,000Source | -17,168,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 12,202,000Source | 13,724,000Source | 12,657,000Source | 6,686,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 381,000Source | 321,000Source | 52,000Source | 237,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -21,000Source | 57,000Source | -50,000Source | -258,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 10,617,000Source | 9,916,000Source | 7,926,000Source | 6,748,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 76,903,000Source | 62,855,000Source | 84,940,000Source | — |
| DepreciationUSD | 1,232,000Source | 1,102,000Source | 1,074,000Source | 979,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | 106,000Source | — | 413,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -35,000Source | — | — | — |
| General and Administrative ExpenseUSD | 8,363,000Source | 6,673,000Source | 7,332,000Source | 10,272,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | -33,762,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | 33,762,000Source |
| Income Tax Expense (Benefit)USD | 121,000Source | 6,000Source | 16,000Source | 20,000Source |
| InterestExpenseNonoperatingUSD | 347,000Source | 303,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -42,627,000Source | -31,750,000Source | -29,157,000Source | -33,762,000Source |
| Nonoperating Income (Expense)USD | -218,000Source | 4,298,000Source | 6,539,000Source | — |
| Proceeds from Issuance of Common StockUSD | 45,496,000Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | 272,000Source | 25,000Source | 49,000Source | 27,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -42,288,000Source | -36,042,000Source | -35,680,000Source | -32,136,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -42,506,000Source | -31,744,000Source | -29,141,000Source | -33,742,000Source |
| Income Tax Expense (Benefit)USD | 121,000Source | 6,000Source | 16,000Source | 20,000Source |
| Net Income (Loss) Attributable to ParentUSD | -42,627,000Source | -31,750,000Source | -29,157,000Source | -33,762,000Source |
| Earnings Per Share, BasicUSD per share | -0.53Source | -0.45Source | -0.42Source | -0.53Source |
| Earnings Per Share, DilutedUSD per share | -0.53Source | -0.45Source | -0.42Source | -0.53Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 80,581,440Source | 69,927,566Source | 69,377,922Source | 63,534,875Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 80,581,440Source | 69,927,566Source | 69,377,922Source | 63,534,875Source |
| Interest Expense (non-operating)USD | 347,000Source | 303,000Source | — | — |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 24,000Source | — | 16,000Source | 20,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | 106,000Source | — | 413,000Source |
| General and Administrative ExpenseUSD | 8,363,000Source | 6,673,000Source | 7,332,000Source | 10,272,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | -33,762,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -42,331,000Source | -31,065,000Source | 28,224,000Source | 33,100,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | 33,762,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | -0.53Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | — | -0.53Source |
| Nonoperating Income (Expense)USD | -218,000Source | 4,298,000Source | 6,539,000Source | — |
| Other ExpensesUSD | — | — | — | 16,547Source |
| Research and Development ExpenseUSD | 32,065,000Source | 27,020,000Source | 26,424,000Source | 20,890,000Source |